| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ | CFO & CBO | Common Stock | 0 | $0 | $45.18 | 04 Dec 2025 | Direct |
| Dianthus Therapeutics, Inc. /DE/ | CFO & CBO | Stock Option (Right to Buy) | 84.8K | 04 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 04 Dec 2025 | 3 | -$735K | 4 | CFO & CBO | 05 Dec 2025, 20:00 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 23 Sep 2025 | 1 | $0 | 4 | CFO & CBO | 25 Sep 2025, 20:02 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 09 Sep 2025 | 3 | -$531K | 4 | CFO & CBO | 11 Sep 2025, 17:20 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 03 Feb 2025 | 1 | $0 | 4 | CFO & CBO | 04 Feb 2025, 16:18 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 23 May 2024 | 1 | $0 | 4 | CFO & CBO | 28 May 2024, 20:04 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 24 Jan 2024 | 1 | $0 | 4 | CHIEF FINANCIAL OFFICER | 26 Jan 2024, 16:41 |
| MGTA | Dianthus Therapeutics, Inc. /DE/ | 11 Sep 2023 | 0 | $0 | 3 | CHIEF FINANCIAL OFFICER | 13 Sep 2023, 20:45 |